We are live on ! Find out more
PAA

Peregrine Asset Advisers Portfolio holdings

AUM $461M
1-Year Est. Return 43.48%
This Fund
S&P 500
This Quarter Est. Return
+20.17%
1 Year Est. Return
+43.48%
3 Year Est. Return
+182.23%
5 Year Est. Return
+276.89%
10 Year Est. Return
+2,104.45%
AUM
$182M
AUM Growth
+$5.6M
Cap. Flow
-$6.16M
Cap. Flow %
-3.39%
Top 10 Hldgs %
33.62%
Holding
123
New
31
Increased
17
Reduced
34
Closed
29

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.63%
2 Industrials 9.81%
3 Technology 8.17%
4 Consumer Discretionary 8.16%
5 Healthcare 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
76
UnitedHealth
UNH
$365B
$312K 0.17%
1,000
PH icon
77
Parker-Hannifin
PH
$134B
$310K 0.17%
+1,531
New +$301K
JPM icon
78
JPMorgan Chase
JPM
$962B
$304K 0.17%
3,160
-1
-0% -$98
ZM icon
79
Zoom
ZM
$31.1B
$275K 0.15%
+584
New +$187K
DIS icon
80
Walt Disney
DIS
$179B
$271K 0.15%
2,185
-100
-4% -$12.5K
PSA icon
81
Public Storage
PSA
$60.7B
$262K 0.14%
1,176
-1
-0.1% -$204
CRM icon
82
Salesforce
CRM
$162B
$257K 0.14%
+1,022
New +$224K
MA icon
83
Mastercard
MA
$491B
$255K 0.14%
753
JBHT icon
84
JB Hunt Transport Services
JBHT
$24.9B
$253K 0.14%
+2,000
New +$266K
EW icon
85
Edwards Lifesciences
EW
$53.9B
$248K 0.14%
3,111
VUG icon
86
Vanguard Morningstar Growth ETF
VUG
$228B
$241K 0.13%
6,360
AEP icon
87
American Electric Power
AEP
$67.3B
$234K 0.13%
2,860
-60
-2% -$4.94K
WST icon
88
West Pharmaceutical
WST
$24.7B
$234K 0.13%
+853
New +$226K
HZNP
89
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$233K 0.13%
+3,000
New +$206K
CVNA icon
90
Carvana
CVNA
$79B
$223K 0.12%
+5,000
New +$177K
BRK.B icon
91
Berkshire Hathaway Class B
BRK.B
$1.11T
$218K 0.12%
+1,025
New +$210K
DDOG icon
92
Datadog
DDOG
$88.8B
$207K 0.11%
+2,025
New +$176K
ABBV icon
93
AbbVie
ABBV
$441B
-18,589
Closed -$1.82M
AMD icon
94
Advanced Micro Devices
AMD
$774B
-5,175
Closed -$272K
AMGN icon
95
Amgen
AMGN
$224B
-1,500
Closed -$354K
AMT icon
96
American Tower
AMT
$79B
-3,250
Closed -$840K
ARE icon
97
Alexandria Real Estate Equities
ARE
$8.28B
-24,659
Closed -$4M
BIIB icon
98
Biogen
BIIB
$30.1B
-1,596
Closed -$427K
CVGW
99
DELISTED
Calavo Growers
CVGW
-4,000
Closed -$252K
DOCU
100
DocuSign
DOCU
$11.3B
-3,121
Closed -$503K

Similar funds

Peregrine Asset Advisers's Q3 2020 Portfolio in Review

As of Q3 2020, Peregrine Asset Advisers held 123 positions worth $182M, up 3.2% from $176M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Peregrine Asset Advisers withdrew a net $6.16M in Q3 2020, closing 29 positions and reducing 34 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $4.47M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

Against the trend, Peregrine Asset Advisers opened a new position in JPMorgan BetaBuilders USD High Yield Corporate Bond ETF worth $7.89M.

  • Peregrine Asset Advisers's largest Q3 2020 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 157,739 shares worth $7.89M.
  • Peregrine Asset Advisers added most to Pfizer in Q3 2020, an estimated $3.51M increase.
  • Peregrine Asset Advisers's biggest Q3 2020 reduction was SPDR Gold Trust, cutting an estimated $6.78M.
  • Peregrine Asset Advisers fully exited Regeneron Pharmaceuticals in Q3 2020, selling an estimated $4.47M.
  • Peregrine Asset Advisers's ten largest holdings make up 34% of its $182M portfolio in Q3 2020.
  • Peregrine Asset Advisers opened 31 new positions and closed 29 in Q3 2020.
  • Peregrine Asset Advisers's portfolio value rose 3.2% quarter-over-quarter to $182M.

Based on Peregrine Asset Advisers's 13F filing for Q3 2020, filed 13 Nov 2020.